| 产品详情 |
| Edit |   |
| Product Name | Histone Lysine Demethylase Inhibitor IX, PBIT |
| Description | Purity ~99% (HPLC). A cell-permeable iron chelating benzisothiazolone compound with microbicide and fungicide properties that acts as a potent, selective, and reversible inhibitor of Jumonji AT-Rich Interactive Domain 1 (JARID1) histone demethylases (IC50 = 3uM for JARID1B). Also blocks the activity of other related demethylases at higher concentration (IC50 = 6, 4.9, and 28uM for JARID1A, JARID1C, and JMJD2E, respectively). However, it does affect the activity of unrelated UTX and JMJD3 H3K27me3 demethylases. HeLa cells overexpressing full length JARID1B show a significant reduction in H3K4Me3 activity following PBIT treatment (~10uM). Blocks the proliferation of UACC-812 tumor cells expressing higher levels of JARDID1B, but does not significantly affect MCF7 or MCF10A cells expressing lower levels of JARDID1B. Primary Target: JARID1 Histone Demethylases Solubility: DMSO |
| Size | 25mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | Histone Lysine Demethylase Inhibitor IX, PBIT (2-(4-Methylphenyl)-1,2-benzisothiazol-3(2H)-one, JHDM Inhibitor V) |
| Gene, Accession, CAS # | n/a |
| Catalog # | 217429 |
| Price | |
| Order / More Info | Histone Lysine Demethylase Inhibitor IX, PBIT from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|